Class 4 Medicines Defect Information: Quadrant Pharmaceuticals Limited, Bezalip Mono 400mg Tablets, EL (22)A/38

Sign up for your FREE ticket to see PharmData at the Pharmacy Show to see our latest products and features demonstrated live!

Class 4 Medicines Defect Information: Quadrant Pharmaceuticals Limited, Bezalip Mono 400mg Tablets, EL (22)A/38

2022-09-12 09:00:51 (3 year(s) ago)

Summary

Quadrant Pharmaceuticals Limited have informed the MHRA of an error with the Patient Information Leaflets (PILs) that have been packaged in various parallel imported batches.

Read full MHRA article

Respond to this alert